...
首页> 外文期刊>Journal of cataract and refractive surgery >Corneal wavefront-guided photorefractive keratectomy in patients with irregular corneas after corneal refractive surgery.
【24h】

Corneal wavefront-guided photorefractive keratectomy in patients with irregular corneas after corneal refractive surgery.

机译:角膜屈光手术后不规则角膜患者的角膜波前引导光折射角膜切除术。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To evaluate the corrective potential of corneal wavefront-guided photorefractive keratectomy (PRK) in patients with high levels of corneal aberrations and symptoms after previous corneal refractive surgery. SETTING: Vissum-Instituto de Oftalmologico de Alicante, Alicante, Spain. METHODS: This study comprised 25 eyes (20 patients) that had 1 or more previous unsuccessful keratorefractive procedure. All eyes had PRK retreatment using the Esiris excimer laser and ORK-CAM software for customized ablation design. All eyes had a high preoperative level of corneal higher-order aberrations (HOAs) (coma-like or spherical-like root mean square [RMS] >0.5 microm). Changes in refractive outcomes, subjective symptoms, and corneal aberrometry were evaluated during a 6-month follow-up. RESULTS: Uncorrected visual acuity improved significantly from preoperatively (mean 0.48) to 6 months after retreatment (mean 0.75) (P<.01). The mean best spectacle-corrected visual acuity (BSCVA) also improved significantly, from 0.78 to 0.90, respectively (P<.01). Forty-four percent of patients gained 1 or more lines of BSCVA. The reduction in cylinder at 6 months was statistically significant (P= .01). Corneal aberrometry at 6 months showed a statistically significant reduction in total (P= .01), spherical-like (P<.01), coma-like (P= .02), and primary coma (P<.01) RMS. At 6 months, 72% of patients had low or no perception of halos and all reported no glare. CONCLUSION: Corneal wavefront-guided PRK enhancement with the ORK-CAM system minimized corneal HOAs in eyes with previous unsuccessful keratorefractive surgery.
机译:目的:评估角膜波前引导下的光折射角膜切除术(PRK)在高水平角膜畸变和症状的患者中的矫正潜力。地点:西班牙阿利坎特,阿利坎特市立圣母学院。方法:本研究包括25眼(20例患者),他们曾接受过1次或多次不成功的屈光手术。使用Esiris准分子激光和ORK-CAM软件对所有眼睛进行了PRK再治疗,以进行定制的消融设计。所有眼睛的术前角膜高阶像差(HOA)水平高(昏迷状或球状均方根[RMS]> 0.5 microm)。在6个月的随访期间评估了屈光结局,主观症状和角膜像差的变化。结果:未矫正的视力从术前(平均0.48)到再治疗后6个月(平均0.75)有显着改善(P <.01)。平均最佳眼镜矫正视力(BSCVA)也显着提高,分别从0.78到0.90(P <.01)。 44%的患者获得了1株或更多株BSCVA。 6个月时的气瓶减少有统计学意义(P = 0.01)。 6个月时的角膜像差测量显示,总体(P = .01),球形(P <.01),昏迷状(P = .02)和原发性昏迷(P <.01)RMS均有统计学意义的降低。在6个月时,有72%的患者对光晕的感知较低或没有感知,所有患者均没有眩光。结论:ORK-CAM系统在角膜波前引导的PRK增强术中可将先前不成功的屈光性屈光手术失败的患者的角膜HOA降至最低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号